Summit shares surged in after-hours trading following the news of AstraZenecaβs investment, as the two companies plan to ramp up their collaboration on developing cancer treatments.
Summit shares surged in after-hours trading following the news of AstraZenecaβs investment, as the two companies plan to ramp up their collaboration on developing cancer treatments.
The semiconductor company said the deal would help it develop better hardware, software and systems, especially in the growing field of physical AI and robotics.